Literature DB >> 8606068

Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung.

S T Kanaly1, S A Hines, G H Palmer.   

Abstract

Rhodococcus equi, and intracellular respiratory pathogen, causes sever e granulomatous pneumonia in humans with AIDS and in young horses. Pulmonary clearance of R. equi requires functional CD4+ T cells and gamma interferon (IFN-gamma) expression from bronchial lymph node cells. The purpose of this study was to investigate whether R. equi-specific CD4+ Th1 cells could effect clearance of R. equi from the lung. Adoptive transfer of a clearance of R. equi from the lungs. In contrast, mice transfused with a R. equi-specific CD4+ Th2 cell line expressed interleukin-4 but not IFN-gamma mRNA, failed to clear pulmonary infection, and developed granulomas in the lung. Control mice, which did not receive cells, did not produce IFN-gamma or interleukin-4 and developed small pulmonary granulomas. These results clearly show that a Th1 response is sufficient to effect pulmonary clearance of R. equi.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606068      PMCID: PMC173893          DOI: 10.1128/iai.64.4.1126-1132.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Virulence of Rhodococcus equi for mice.

Authors:  M Nakazawa; M Haritani; C Sugimoto; Y Isayama
Journal:  Nihon Juigaku Zasshi       Date:  1983-10

2.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

3.  Selective medium for Corynebacterium equi isolation.

Authors:  J B Woolcock; A M Farmer; M D Mutimer
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

Review 4.  Bacterial pneumonia in HIV-infected patients.

Authors:  C L Daley
Journal:  Semin Respir Infect       Date:  1993-06

Review 5.  Treatment of Corynebacterium equi pneumonia of foals: a review.

Authors:  J F Prescott; C R Sweeney
Journal:  J Am Vet Med Assoc       Date:  1985-10-01       Impact factor: 1.936

Review 6.  Animal-associated opportunistic infections among persons infected with the human immunodeficiency virus.

Authors:  C A Glaser; F J Angulo; J A Rooney
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

7.  An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection.

Authors:  T A Wynn; A W Cheever; D Jankovic; R W Poindexter; P Caspar; F A Lewis; A Sher
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

8.  Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

Authors:  M Clerici; D R Lucey; J A Berzofsky; L A Pinto; T A Wynn; S P Blatt; M J Dolan; C W Hendrix; S F Wolf; G M Shearer
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

9.  Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.

Authors:  H W Murray; J Hariprashad
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  17 in total

1.  Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins.

Authors:  B A Byrne; J F Prescott; G H Palmer; S Takai; V M Nicholson; D C Alperin; S A Hines
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Authors:  A Marianela Lopez; Melissa T Hines; Guy H Palmer; Debra C Alperin; Stephen A Hines
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Authors:  Seth P Harris; Melissa T Hines; Robert H Mealey; Debra C Alperin; Stephen A Hines
Journal:  Vet Immunol Immunopathol       Date:  2011-03-21       Impact factor: 2.046

4.  Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.

Authors:  Stephen A Hines; Diana M Stone; Melissa T Hines; Debby C Alperin; Donald P Knowles; Linda K Norton; Mary J Hamilton; William C Davis; Travis C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi.

Authors:  S Giguère; B N Wilkie; J F Prescott
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.

Authors:  Stephanie Jacks; Steeve Giguère; P Cynda Crawford; William L Castleman
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

7.  Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.

Authors:  Kathleen E Hooper-McGrevy; Bruce N Wilkie; John F Prescott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection.

Authors:  Andrea K Kohler; Diana M Stone; Melissa T Hines; Barbara A Byrne; Debra C Alperin; Linda K Norton; Stephen A Hines
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection.

Authors:  M Julia B F Flaminio; Daryl V Nydam; Hélène Marquis; Mary Beth Matychak; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.